Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Shizuoka Cancer Center, Tokyo National Hospital, National Cancer Center Hospital East, Kobe University, Ogaki Municipal Hospital, Aichi Cancer Center, Osaka National Hospital, Saitama Cancer Center, Kanagawa Prefectural Hospital Organization, Kanagawa Cancer Center, Chiba Cancer Center, Asahikawa Medical University, Jichi Medical University, Tochigi Cancer Center, Hyogo Prefectural Cancer Center, Kasugai Municipal Hospital, Hokkaido University, Kure Medical Center, National Hospital Organization, Chuo University